drug therapy plans for asthmatic patients
Asthma is a respiratory disorder that affects children and adults. Advanced practice nurses often provide treatment to patients with these disorders. Sometimes patients require immediate treatment, making it essential that you recognize and distinguish minor asthma symptoms from serious, life-threatening ones. Since symptoms and attacks are often induced by a trigger, advanced practice nurses must also help patients identify their triggers and recommend appropriate management options. Like many other disorders, there are various approaches to treating and managing care for asthmatic patients depending on individual patient factors.Photo Credit: Photo Library / Getty ImagesOne method that supports the clinical decision making of drug therapy plans for asthmatic patients is the stepwise approach, which you explore in this Assignment.To PrepareReflect on drugs used to treat asthmatic patients, including long-term control and quick relief treatment options for patients. Think about the impact these drugs might have on patients, including adults and children.Consider how you might apply the stepwise approach to address the health needs of a patient in your practice.Reflect on how stepwise management assists health care providers and patients in gaining and maintaining control of the disease.BELOW IS THE QUESTION—————–Create a 5 slide PowerPoint presentation that can be used in a staff development meeting on presenting different approaches for implementing the stepwise approach for asthma treatment. Be sure to address the following:Describe long-term control and quick relief treatment options for the asthma patient from your practice as well as the impact these drugs might have on your patient.Explain the stepwise approach to asthma treatment and management for your patient.Explain how stepwise management assists health care providers and patients in gaining and maintaining control of the disease. Be specific.BELOW IS THE REQUIRED READING—————Learning ResourcesRequired Readings (click to expand/reduce)Rosenthal, L. D., & Burchum, J. R. (2021). Lehne’s pharmacotherapeutics for advanced practice nurses and physician assistants (2nd ed.) St. Louis, MO: Elsevier.Chapter 62, “Drugs for Asthma and Chronic Obstructive Pulmonary Disease” (pp. 557-579)Chapter 63, “Drugs for Allergic Rhinitis, Cough, and Colds” (pp. 580-588)PLEASE MAKE SURE TO ADD 5 REFERENCES NOT MORE THAN 5 YEARS OLD WITH PROPER CITATION and please go through the presentation template and rubic CORE SKILL: STEPWISE management — the therapy is titrated to CONTROL, and the drugs are divided by whether they treat the disease or the symptom.
THE TWO CATEGORIES, and the distinction that matters most: LONG-TERM CONTROL medications (taken daily, treat the underlying INFLAMMATION) vs. QUICK-RELIEF/RESCUE (treat acute bronchospasm). INHALED CORTICOSTEROIDS ARE THE CORNERSTONE of control because asthma is fundamentally an INFLAMMATORY disease, not a bronchoconstrictive one — bronchoconstriction is the consequence. That single sentence explains why a patient using their rescue inhaler daily is UNCONTROLLED and undertreated, not well-managed. Rescue-inhaler overuse (>2 canisters/year, or use >2 days/week) is a marker of poor control AND an independent predictor of asthma death.
THE CLASSES:
— SABA (albuterol): rescue. Beta-2 agonist, minutes to onset. Side effects: tremor, tachycardia, hypokalemia.
— ICS (fluticasone, budesonide): first-line controller. Local side effects — oral candidiasis and dysphonia — PREVENTED BY RINSING AND SPITTING AFTER USE and by a spacer. Teaching that is a real clinical point.
— LABA (salmeterol, formoterol): NEVER AS MONOTHERAPY IN ASTHMA — there is a boxed warning; LABA monotherapy increases asthma-related death. Always combined with an ICS. This is the highest-stakes safety point in the topic.
— LTRA (montelukast): oral, useful with allergic rhinitis or exercise-induced asthma; carries an FDA BOXED WARNING for serious NEUROPSYCHIATRIC EVENTS (agitation, depression, suicidality) — counsel and monitor.
— LAMA (tiotropium), oral corticosteroids for exacerbations, and BIOLOGICS for severe disease (omalizumab/anti-IgE; mepolizumab and benralizumab/anti-IL-5 for eosinophilic phenotype; dupilumab).
IMPORTANT CURRENT GUIDANCE worth citing: GINA now recommends ICS-FORMOTEROL as reliever therapy (anti-inflammatory reliever, or “SMART”/MART regimens) rather than SABA alone even in mild asthma, precisely because SABA-only treatment leaves inflammation untreated. Citing this shows currency.
THE STEPWISE LOGIC: assess SEVERITY at diagnosis to select the starting step; assess CONTROL at follow-up to STEP UP or STEP DOWN. Before ever stepping up, CHECK THE THREE THINGS: (1) INHALER TECHNIQUE — most patients use their device incorrectly, and this is the single most common reason for apparent treatment failure; (2) ADHERENCE; (3) environmental triggers and comorbidities (allergic rhinitis, GERD, obesity, smoking). Stepping up therapy in a patient with poor inhaler technique is the classic error the assignment is designed to catch.
LIFESPAN DIFFERENCES the rubric requires: children — dosing differs, spacers with masks for the very young, growth velocity monitoring with ICS (effect is small and largely on attained height, not a reason to withhold treatment), and montelukast neuropsychiatric caution is especially salient. Adults/elderly — comorbid COPD (asthma-COPD overlap), beta-blocker caution, cardiovascular effects of beta-agonists, osteoporosis with chronic oral steroids.
ALSO KNOW: asthma action plan (green/yellow/red zones), peak flow monitoring, and spirometry showing REVERSIBLE obstruction (≥12% and 200 mL improvement in FEV1 post-bronchodilator) — reversibility is what distinguishes asthma from COPD.
Collepals.com Plagiarism Free Papers
Are you looking for custom essay writing service or even dissertation writing services? Just request for our write my paper service, and we'll match you with the best essay writer in your subject! With an exceptional team of professional academic experts in a wide range of subjects, we can guarantee you an unrivaled quality of custom-written papers.
Get ZERO PLAGIARISM, HUMAN WRITTEN ESSAYS
Why Hire Collepals.com writers to do your paper?
Quality- We are experienced and have access to ample research materials.
We write plagiarism Free Content
Confidential- We never share or sell your personal information to third parties.
Support-Chat with us today! We are always waiting to answer all your questions.
